Cerebral Embolic Protection in TAVR

Northwell Fellows Course 2020

A. Tariq

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

Intra-Aortic Balloon Pump: New Insights

David Baran

Contemporary Management of Cardiogenic Shock: Updates in 2022

Mount Sinai Advanced Innovations in Heart Failure

D. Baran

The Past, Present and Future of the Total Artificial Heart

The Texas Heart Institute

W. Cohn, O. Frazier

Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Use of MCS in Management of Acute Post-MI VSD

Houston Shock Symposium

D. Ramini

Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?

American Heart & Vascular Institute

M. Ansari

Femoral Access

Northwell Fellows Course 2020

M. Kim

The Other Option for Hemodynamic Support in High Risk PCI

Joseph Thomas

Incorporating Coronary Physiology in Decision Making

San Diego Cardiovascular Interventions (SDCI) 2017

M. Kern

ACP 2024 Insights: Acute Coronary Syndromes - Evaluation, Diagnosis …

Insights from 2024 ACP Annual Meeting

D. Berg

Cardiogenic Shock: Treatment Options

NYU Langone

S. Hall

Expanded Indications of Impella Protected PCI

Complex Coronary Cases

J. Lasala